ArticleERJ open research2026

Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.

Ebrahim AlEissa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.